Immunotherapy approaches for the treatment of diffuse midline gliomas

JD Bernstock, SE Hoffman, AD Kappel… - …, 2022 - Taylor & Francis
Diffuse midline gliomas (DMG) are a highly aggressive and universally fatal subgroup of
pediatric tumors responsible for the majority of childhood brain tumor deaths. Median overall …

Pediatric diffuse midline gliomas: an unfinished puzzle

V Di Ruscio, G Del Baldo, F Fabozzi, M Vinci… - Diagnostics, 2022 - mdpi.com
Diffuse midline glioma (DMG) is a heterogeneous group of aggressive pediatric brain tumors
with a fatal prognosis. The biological hallmark in the major part of the cases is H3K27 …

MobileNetV1-based deep learning model for accurate brain tumor classification

MM Mijwil, R Doshi, KK Hiran… - Mesopotamian …, 2023 - journals.mesopotamian.press
Brain tumors are among the most dangerous diseases that lead to mortality after a period of
time from injury. Therefore, physicians and healthcare professionals are advised to make an …

Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study

K Cheng, H Zhang, Q Guo, P Zhai, Y Zhou… - Frontiers in …, 2022 - frontiersin.org
Background Central nervous system tumor (CNST) is one of the most complicated and lethal
forms of human tumors with very limited treatment options. In recent years, growing evidence …

Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments

L Feldman - Frontiers in Immunology, 2024 - frontiersin.org
Glioblastoma (GBM) tumors are the most aggressive primary brain tumors in adults that,
despite maximum treatment, carry a dismal prognosis. GBM tumors exhibit tissue hypoxia …

Development and application of oncolytic viruses as the nemesis of tumor cells

X Zhu, C Fan, Z Xiong, M Chen, Z Li, T Tao… - Frontiers in …, 2023 - frontiersin.org
Viruses and tumors are two pathologies that negatively impact human health, but what
occurs when a virus encounters a tumor? A global consensus among cancer patients …

Systemic delivery of tannic acid-ferric-masked oncolytic adenovirus reprograms tumor microenvironment for improved therapeutic efficacy in glioblastoma

G Wang, M Mu, Z Zhang, Y Chen, N Yang… - Cancer Gene …, 2024 - nature.com
Glioblastoma (GBM) represents the most aggressive primary brain tumor, and urgently
requires effective treatments. Oncolytic adenovirus (OA) shows promise as a potential …

Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma

JT Low, MC Brown, ZJ Reitman… - The Journal of …, 2024 - Am Soc Clin Investig
Since the discovery that cGAS/STING recognizes endogenous DNA released from dying
cancer cells and induces type I interferon and antitumor T cell responses, efforts to …

Gene therapy for high grade glioma: the clinical experience

ML Varela, A Comba, SM Faisal, A Argento… - Expert opinion on …, 2023 - Taylor & Francis
Introduction High-grade gliomas (HGG) are the most common malignant primary brain
tumors in adults, with a median survival of~ 18 months. The standard of care (SOC) is …

Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations

MMA Shirazi, TA Saedi, ZS Moghaddam… - Pharmacology & …, 2024 - Elsevier
Abstract Oncolytic adenoviruses (OAds), engineered Ads preferentially infect and lyse tumor
cells, have attracted remarkable attention as immunotherapy weapons for the treatment of …